BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 19/07/2007

FDA Clears Terbutaline Sulfate Injection for Approval

The FDA has determined that Brethine (Terbutaline Sulfate) Injection was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications for the medication.

Source: Federal Register — Food and Drug AdministrationOpen original release →